Eflornithine / Metformin Cream Compounded

Description

Topical eflornithine and topical metformin are emerging as innovative, targeted therapies that influence follicular activity through distinct molecular pathways.

Active Ingredients & How They Work

Eflornithine — Originally developed as an antiparasitic medication, but later found dermatologic utility due to its ability to inhibit ornithine decarboxylase (ODC) — a key enzyme in the biosynthesis of polyamines such as putrescine, spermidine, and spermine. These polyamines regulate cellular proliferation and differentiation, particularly within actively dividing tissues like hair follicles. Acts enzymatically by blocking ODC and depleting polyamine availability — directly curtailing follicular matrix activity.

Metformin — A biguanide class insulin-sensitizing agent, has long been used to treat hyperglycemia in type 2 diabetes mellitus. Its mechanism centers on the activation of AMP-activated protein kinase (AMPK), which reduces hepatic glucose output and enhances peripheral insulin uptake. Acts metabolically via AMPK activation to suppress anabolic signaling through mTOR — improving the local hormonal and inflammatory milieu.

🧪 How It Works

By irreversibly inhibiting ODC, eflornithine reduces polyamine synthesis, slowing matrix keratinocyte division and delaying the initiation of new hair shafts. This mechanism selectively reduces the rate of terminal hair growth without damaging existing follicles.

Clinical Evidence

Clinical studies of topical eflornithine cream have demonstrated statistically significant reductions in hair growth after 6 to 8 weeks of twice-daily use. Improvements are typically maintained with continuous application, and adverse effects are limited to mild erythema, burning, or stinging sensations.

In PCOS, metformin also exerts endocrine effects by lowering circulating insulin levels, thereby reducing ovarian androgen synthesis and restoring more physiologic gonadotropin signaling.

Typical Compounding Concentrations

– Eflornithine HCl: 13.9% to 15% in hydrophilic base

– Metformin HCl: 3% to 10%, with 5% being most studied in dermatologic settings

What to Expect

Patients using topical eflornithine or metformin should be advised that results develop gradually, typically within two to three hair cycles. Consistency of use is key — skipping applications can allow follicles to return to their natural growth rate. When used as prescribed, these agents can reduce the frequency of hair removal and improve skin texture over time.

Their complementary mechanisms — enzymatic inhibition and metabolic modulation — address the multifactorial nature of hair growth regulation at its root.

Read the full clinical article: Understanding How Topical Eflornithine and Metformin Regulate Hair Growth
→